GLG Partners’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$949K Sell
6,500
-7,000
-52% -$997K 0.04% 300
2017
Q3
$1.83M Sell
13,500
-3,500
-21% -$442K 0.1% 196
2017
Q2
$2.13M Hold
17,000
0.12% 195
2017
Q1
$2.02M Hold
17,000
0.09% 230
2016
Q4
$1.96M Sell
17,000
-3,500
-17% -$389K 0.08% 226
2016
Q3
$2.14M Buy
20,500
+2,500
+14% +$261K 0.07% 284
2016
Q2
$1.75M Buy
+18,000
New +$1.7M 0.05% 296
2015
Q3
Sell
-144,114
Closed -$13.4M 481
2015
Q2
$13.4M Buy
144,114
+116,183
+416% +$10.8M 0.35% 84
2015
Q1
$2.65M Sell
27,931
-122,268
-81% -$11.3M 0.09% 220
2014
Q4
$13.3M Buy
150,199
+108,748
+262% +$9.22M 0.39% 77
2014
Q3
$3.31M Buy
+41,451
New +$3.12M 0.08% 254
2014
Q2
Sell
-486,181
Closed -$36M 377
2014
Q1
$36M Buy
486,181
+338,534
+229% +$25.5M 0.71% 36
2013
Q4
$11.6M Buy
+147,647
New +$11.6M 0.81% 39

Other funds holding CME

GLG Partners's CME Position: Q4 2017 in Review

GLG Partners reduced its CME Group (CME) stake by 52% in Q4 2017, selling an estimated $997K and leaving 6,500 shares worth $949K. The position accounts for 0.04% of the portfolio, ranked #300.

GLG Partners first reported a position in CME in Q4 2013 and has held it in 13 quarters since. The position peaked at $36M in Q1 2014. 857 funds tracked by Wall St. Rank hold CME as of Q4 2017.

  • GLG Partners held 6,500 shares of CME Group worth $949K as of Q4 2017.
  • GLG Partners sold 7,000 CME Group shares in Q4 2017, an estimated $997K.
  • CME Group made up 0.04% of GLG Partners's portfolio in Q4 2017, its #300 holding.
  • GLG Partners first reported a position in CME Group in Q4 2013 and has held it in 13 quarters since.
  • GLG Partners's CME Group position peaked at $36M in Q1 2014.
  • 857 funds tracked by Wall St. Rank held CME Group as of Q4 2017.

Based on GLG Partners's 13F filing for Q4 2017, filed 14 Feb 2018.